Quick Answer
CHAMPIONS ONCOLOGY, INC. reported Total Assets of $32.34 million for the year ending 2025.
- CHAMPIONS ONCOLOGY, INC. showed an increase of +23.8% in Total Assets from 2024 to 2025.
- This data is from CHAMPIONS ONCOLOGY, INC.'s annual report (Form 10-K), filed with the SEC on July 23, 2025.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2011: $11.80 million | Q4 2011: $9.87 million | Q1 2012: $8.87 million | Q3 2012: $5.15 million | Q4 2012: $4.23 million | Q1 2013: $13.01 million | Q3 2013: $10.67 million | Q4 2013: $10.50 million | Q1 2014: $10.47 million | Q3 2014: $5.68 million | Q4 2014: $3.31 million | Q1 2015: $2.83 million | Q3 2015: $9.85 million | Q4 2015: $7.58 million | Q1 2016: $7.15 million | Q4 2016: $8.04 million | Q1 2017: $7.55 million | Q3 2017: $6.47 million | Q4 2017: $6.49 million | Q1 2018: $7.10 million | Q3 2018: $8.39 million | Q4 2018: $10.24 million | Q1 2019: $10.91 million | Q3 2019: $13.36 million | Q4 2019: $13.95 million | Q1 2020: $15.08 million | Q3 2020: $22.82 million | Q4 2020: $25.76 million | Q1 2021: $25.26 million | Q3 2021: $28.11 million | Q4 2021: $29.30 million | Q1 2022: $33.58 million | Q3 2022: $34.39 million | Q4 2022: $36.36 million | Q1 2023: $36.15 million | Q3 2023: $29.91 million | Q4 2023: $28.29 million | Q1 2024: $26.79 million | Q3 2024: $24.93 million | Q4 2024: $25.24 million | Q1 2025: $30.63 million | Q2 2025: $32.34 million | Q3 2025: $30.55 million | Q4 2025: $30.16 million | Q1 2026: $28.45 million.
- Over the full 15 years of available data (2011 to 2025), CHAMPIONS ONCOLOGY, INC.'s Total Assets has grown by 155.7%.
- Historical annual values: Fiscal year 2025: $32.34 million | Fiscal year 2024: $26.13 million | Fiscal year 2023: $34.31 million | Fiscal year 2022: $35.38 million | Fiscal year 2021: $27.59 million | Fiscal year 2020: $20.75 million | Fiscal year 2019: $11.27 million | Fiscal year 2018: $8.08 million | Fiscal year 2017: $8.01 million | Fiscal year 2016: $5.78 million | Fiscal year 2015: $12.05 million | Fiscal year 2014: $8.87 million | Fiscal year 2013: $11.65 million | Fiscal year 2012: $6.92 million | Fiscal year 2011: $12.65 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: